Correlations of disease severity outcome measures in inclusion body myositis

被引:7
作者
Goyal, Namita A. [1 ,8 ]
Greenberg, Steven A. [2 ]
Cauchi, Jonathan [1 ]
Araujo, Nadia [1 ]
Li, Vivian [1 ]
Wencel, Marie [1 ]
Irani, Tyler [1 ]
Wang, Leo H. [3 ]
Palma, Anton M. [4 ]
Villalta, S. Armando [1 ,5 ,6 ]
Mozaffar, Tahseen [1 ,5 ,7 ]
机构
[1] Univ Calif Irvine, Dept Neurol, Irvine, CA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA USA
[3] Univ Washington, Dept Neurol, Med Ctr, Seattle, WA USA
[4] Univ Calif Irvine, Inst Clin & Translat Sci, Irvine, CA USA
[5] Univ Calif Irvine, Inst Immunol, Irvine, CA USA
[6] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA USA
[7] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA
[8] UC Irvine, MDA ALS & Neuromuscular Ctr, 200 S Manchester Ave,Suite 110, Orange, CA 92868 USA
关键词
Inclusion body myositis; Outcome measures; Clinical trials; IBMFRS; PROGRESSION;
D O I
10.1016/j.nmd.2022.08.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study aimed to evaluate the correlation between various outcome measures used to assess disease severity and progression in inclusion body myositis (IBM) clinical trials. A cross-sectional study, involving 51 IBM patients meeting the European Neuromuscular Center (ENMC) 2011 criteria for clinically defined or probable IBM, was completed at the University of California, Irvine. Clinical details, demographic data, and functional data including timed get up (TGU), manual muscle testing, hand grip, pinch dynamometry, as well as IBM functional rating scale (IBMFRS), modified Rankin score, forced vital capacity (FVC), and modified ocular bulbar facial respiratory scale (mOBFRS) were collected on all patients. Descriptive statistics and Pearson's r correlation were performed to analyze the data. Age of the patient did not correlate with any of the outcome measures. Greater severity of IBMFRS scores correlated with longer disease duration as well as greater severity for FVC, strength outcomes, TGU, modified Rankin, and mOBFRS. Additionally, TGU strongly correlated with muscle strength measurements, modified Rankin, and mOBFRS. mOBFRS moderately correlated with IBMFRS, muscle strength, FVC, TGU and modified Rankin score. We demonstrate moderate to strong correlations among the disease severity outcome measures in this study.(c) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页码:800 / 805
页数:6
相关论文
共 18 条
[1]   Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis [J].
Allenbach, Yves ;
Benveniste, Olivier ;
Decostre, Valerie ;
Canal, Aurelie ;
Eymard, Bruno ;
Herson, Serge ;
Bloch-Queyrat, Coralie ;
Hogrel, Jean-Yves .
NEUROMUSCULAR DISORDERS, 2012, 22 (11) :980-986
[2]  
Benveniste O, 2017, ARTHRITIS RHEUMATOL, V69
[3]  
Chan Y H, 2003, Singapore Med J, V44, P614
[4]   Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials [J].
Cortese, A. ;
Machado, P. ;
Morrow, J. ;
Dewar, L. ;
Hiscock, A. ;
Miller, A. ;
Brady, S. ;
Hilton-Jones, D. ;
Parton, M. ;
Hanna, M. G. .
NEUROMUSCULAR DISORDERS, 2013, 23 (05) :404-412
[5]   THE OCULOBULBAR FACIAL RESPIRATORY SCORE IS A TOOL TO ASSESS BULBAR FUNCTION IN MYASTHENIA GRAVIS PATIENTS [J].
Farrugia, Maria E. ;
Harle, Heather D. ;
Carmichael, Caroline ;
Burns, Ted M. .
MUSCLE & NERVE, 2011, 43 (03) :329-334
[6]   Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells [J].
Goyal, Namita A. ;
Coulis, Gerald ;
Duarte, Jorge ;
Farahat, Philip K. ;
Mannaa, Ali H. ;
Cauchii, Jonathan ;
Irani, Tyler ;
Araujo, Nadia ;
Wang, Leo ;
Wencel, Marie ;
Li, Vivian ;
Zhang, Lishi ;
Greenberg, Steven A. ;
Mozaffar, Tahseen ;
Villalta, S. Armando .
NEUROLOGY, 2022, 98 (13) :E1374-E1383
[7]   Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial [J].
Hanna, Michael G. ;
Badrising, Umesh A. ;
Benveniste, Olivier ;
Lloyd, Thomas E. ;
Needham, Merrilee ;
Chinoy, Hector ;
Aoki, Masashi ;
Machado, Pedro M. ;
Liang, Christina ;
Reardon, Katrina A. ;
de Visser, Marianne ;
Ascherman, Dana P. ;
Barohn, Richard J. ;
Dimachkie, Mazen M. ;
Miller, James A. L. ;
Kissel, John T. ;
Oskarsson, Bjoern ;
Joyce, Nanette C. ;
Van den Bergh, Peter ;
Baets, Jonathan ;
De Bleecker, Jan L. ;
Karam, Chafic ;
David, William S. ;
Mirabella, Massimiliano ;
Nations, Sharon P. ;
Jung, Hans H. ;
Pegoraro, Elena ;
Maggi, Lorenzo ;
Rodolico, Carmelo ;
Filosto, Massimiliano ;
Shaibani, Aziz, I ;
Sivakumar, Kumaraswamy ;
Goyal, Namita A. ;
Mori-Yoshimura, Madoka ;
Yamashita, Satoshi ;
Suzuki, Naoki ;
Katsuno, Masahisa ;
Murata, Kenya ;
Nodera, Hiroyuki ;
Romano, Carla D. ;
Williams, Valerie S. L. ;
Vissing, John ;
Auberson, Lixin Zhang ;
Wu, Min ;
de Vera, Ana ;
Papanicolaou, Dimitris A. ;
Amato, Anthony A. ;
Nishino, Ichizo .
LANCET NEUROLOGY, 2019, 18 (09) :834-844
[8]   Still seeking the holy grail of outcome measures in inclusion body myositis [J].
Hogrel, Jean-Yves .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (08) :802-803
[9]   Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: Implications for therapeutic trials [J].
Hogrel, Jean-Yves ;
Allenbach, Yves ;
Canal, Aurelie ;
Leroux, Gaelle ;
Ollivier, Gwenn ;
Mariampillai, Kuberaka ;
Servais, Laurent ;
Herson, Serge ;
Decostre, Valerie ;
Benveniste, Olivier .
NEUROMUSCULAR DISORDERS, 2014, 24 (07) :604-610
[10]   Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity [J].
Jackson, C. E. ;
Barohn, R. J. ;
Gronseth, G. ;
Pandya, S. ;
Herbelin, L. .
MUSCLE & NERVE, 2008, 37 (04) :473-476